GH vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

GH

50.2
AI Score
VS
GH Wins

MEDP

47.5
AI Score

Investment Advisor Scores

GH

50score
Recommendation
HOLD

MEDP

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GH MEDP Winner
Forward P/E 0 35.3357 Tie
PEG Ratio 0 3.256 Tie
Revenue Growth 44.3% 17.2% GH
Earnings Growth 0.0% 37.1% MEDP
Tradestie Score 50.2/100 47.5/100 GH
Profit Margin -38.3% 17.7% MEDP
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GH 1M: +13.6% · 3M: +44.6% MEDP 1M: +2.5% · 3M: +44.3%

Current Technical Phase

GH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 63

RSI (14): 62.7 · Price: $170.69

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.4% over 20 days), RSI 67

RSI (14): 66.6 · Price: $620.75

Fundamentals Snapshot

Metric GH MEDP
Market Cap
Forward P/E -379.2 32.2
Trailing P/E 36.0
Revenue (TTM)
Revenue Growth 0.4% 0.2%
Gross Margin 0.7% 0.7%
Operating Margin -0.4% 0.2%
EPS -3.61 17.04
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.